Clinical trials

2

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Feasibility Study to Investigate Rectal Mucus in Aero-Digestive Tract Cancer.

The aim of the study is to assess the feasibility of genomic and epigenetic analysis of rectal mucus to detect non-colorectal cancers of the aero- digestive tract using samples collected by the OriCol™ Sampling Device. The primary objective of the study is to assess whether significant changes in DNA mutation and methylation associated with Non-colorectal cancers of the Aero-digestive Tract (NCRCADT) can be detected in rectal mucus as shed cells and cell-free DNA (cfDNA) pass through the gut and theoretically can be collected from rectal mucus. Secondary objectives will assess the participant acceptability of the OriCol™ Sampling Device for Pancreatic Ductal Adenocarcinoma, Non-Small Cell Cancer of the Lung, Colorectal Cancer and Urological Cancer controls as well as contributing to a genomic library collating information about rectal mucus.

Participants needed: 450
Trial details
Age: 18-99Biological sex: AllType: ObservationalSponsor: Origin SciencesUpdated: Mar 16, 2026Locations: 1
Eligibility criteria

Not listed

Status: Recruiting

Triple Assay of Rectal Mucus in the Diagnosis of Colorectal Cancer

Development of a multiomics assay for use on OriColTM sampled rectal mucus for detection of cancer and significant polyps in symptomatic patients on the Colorectal Urgent Suspected Cancer pathway.

Participants needed: 6,600
Trial details
Age: 18-99Biological sex: AllType: ObservationalSponsor: Origin SciencesUpdated: Apr 4, 2025Locations: 1
Eligibility criteria

Patients 18 years and over [+2]

Patients who are unable to undergo digital rectal examination (DRE). [+7]